about
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptorsiRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migrationThe Endocannabinoid System in the Postimplantation Period: A Role during Decidualization and PlacentationThe putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivoN-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory propertiesCannabinoids in health and diseaseNovel endogenous peptide agonists of cannabinoid receptorsReceptors for acylethanolamides-GPR55 and GPR119The endocannabinoid system as an emerging target of pharmacotherapyGPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M currentEndocannabinoids in the retina: from marijuana to neuroprotectionThe orphan receptor GPR55 is a novel cannabinoid receptorThe novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effectsNovel cannabinoid receptorsHemopressin is an inverse agonist of CB1 cannabinoid receptorsModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionCannabinoids, endocannabinoids, and cancerCB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune DysregulationΔ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cellsPharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndromeProlonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liabilityRegression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the FutureEnhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modalityEndocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediatorPsychopharmacology of the endocannabinoids: far beyond anandamide.Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null miceThe promise and dilemma of cannabinoid therapy: lessons from animal studies of bone disease.Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.'Crazy Monkey' poisons man and dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid.Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors.The endocannabinoid system and painThe PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain.Endocannabinoids in liver disease.The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus.Molecular composition of the endocannabinoid system at glutamatergic synapses.Comparative effects of chlorpyrifos in wild type and cannabinoid Cb1 receptor knockout mice.Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotectionCannabinoid receptors and endocannabinoids: evidence for new players.
P2860
Q21093349-F3450A5B-F267-41B8-98A5-1695A0E7358DQ21202826-9A161218-17E6-4825-A963-995DDEA87420Q21284856-396EE066-194A-484B-BDF9-5CD14EE453E9Q24322122-AF99E466-0F49-4A6B-AAF3-953B4158457FQ24541462-8C776BBC-40FE-4CA5-9F6A-4698C0344554Q24633884-774D6294-9ABC-4F2E-82D4-FA6D413E182AQ24644673-75006124-D1BE-4784-A143-12DBF313CFB0Q24647538-28651834-F944-4E7A-88CB-E0033AD1A71BQ24648473-BD631E5B-BE6B-4CA3-8A9A-64FD74125B6DQ24653442-9B6FE731-72E0-4A28-9377-96C326D53AB8Q24656049-D63D2326-0C89-4208-B3E3-3B0BB1C15AA9Q24670137-66F18DA9-5296-4A75-A3AA-867A5D3D3050Q24681369-B8BD5E2D-D905-49CE-93B9-5EB6AD8207C7Q24681482-968228CF-3DEC-42AD-812B-ADF8876C80E0Q24683759-449F7186-021A-4B02-B05A-9D8C4C230F92Q27014154-D3342184-FEFB-4241-8014-FF737DA32681Q27694715-FB2E299C-8D9B-4D5C-BDF2-08781E3EC702Q28072822-D23B2E0F-4297-4F4B-9A8A-2C808B274DDBQ28238141-C91B3EF3-3761-4844-A571-8F7B21657691Q28244460-791C899A-2F92-47A5-9C28-5546B052AB81Q30506148-60049D92-D2EC-4F2C-A91E-C9C91E5BB6F4Q33751118-86C27486-6C24-4719-84B7-16A9CB7092ABQ33920996-6E392200-C230-4E28-B517-179DC79455FBQ33980198-4504B2C4-A96C-4FC8-BC89-7574B226EAF3Q34018061-025B2395-51F3-4B0B-B8D4-BC6BD4A24494Q34116761-92CC02D7-6723-47E9-A6AC-8B2FDF157444Q34190754-23FAAA8C-9A19-4BC4-AAB5-15B4888D7241Q34238768-CC691BEC-A63D-4666-8754-EC4AA5723F15Q34393890-CC728619-2F47-4D82-A88A-C4A017BFEC1EQ34402180-5A62A460-CE11-405C-BF93-24D5579D5199Q34423408-E339FDA9-1BAB-48F1-82CB-EC7D3CC6EDA5Q34574015-83636EB6-C276-4608-A352-EE4F06177ACBQ34612917-75A15BF9-07A7-4005-8120-DDA8E0B315ABQ34613459-CB4DC0FE-7008-4669-982F-7759E47B7193Q34776919-68F7FCEB-627B-4680-BAF0-F23D661D738AQ35072848-2F168117-D8E0-429F-88C8-16B1DEDE4460Q35220762-8107F12B-9DD0-456A-B702-206C1510E429Q35489737-0A147645-196D-4136-A976-87FF9691BBF1Q35499568-D65C5C81-870F-41F0-97C7-DA318E4AB862Q35594830-099B462F-A1B4-4CB8-AFC0-0F3051FA0F6C
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Evidence for novel cannabinoid receptors.
@ast
Evidence for novel cannabinoid receptors.
@en
Evidence for novel cannabinoid receptors.
@nl
type
label
Evidence for novel cannabinoid receptors.
@ast
Evidence for novel cannabinoid receptors.
@en
Evidence for novel cannabinoid receptors.
@nl
prefLabel
Evidence for novel cannabinoid receptors.
@ast
Evidence for novel cannabinoid receptors.
@en
Evidence for novel cannabinoid receptors.
@nl
P2093
P50
P921
P1476
Evidence for novel cannabinoid receptors.
@en
P2093
Fong Ming Mo
George Kunos
László Offertáler
Sándor Bátkai
P304
P356
10.1016/J.PHARMTHERA.2004.11.005
P577
2005-01-11T00:00:00Z